Катастрофический антифосфолипидный синдром и тромбозы

1. Rodríguez-Pintó I., Moitinho M., Santacreu I., Shoenfeld Y., Erkan D., Espinosa G. et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun. Rev. 2016; 15(12): 1120-4.
2. Silver R.M. Catastrophic antiphospholipid syndrome and pregnancy. Semin. Perinatol. 2018; 42(1): 26-32.
3. Hughes G.R. Thrombosis, abortion, cerebral disease, and lupus anticoagulant. Br. Med. J. (Clin. Res. Ed). 1983; 287(6399): 1088-9.
4. Greisman S.G., Thayaparan R.S., Godwin T.A., Lockshin M.D. Occlusive vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody. Arch. Intern. Med. 1991; 151(2): 389-92.
5. Макацария А.Д., ред. Системные синдромы в акушерско-гинекологической клинике. М.: МИА; 2010: 359-60.
6. Cervera R., Bucciarelli S., Plasín M.A., Gómez-Puerta J.A., Plaza J., Pons-Estel G. et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the «CAPS Registry». J. Autoimmun. 2009; 32(3-4): 240-5.
7. Cervera R., Rodríguez-Pintó I., Colafrancesco S., Conti F., Valesini G., Rosário C. et al. 14th International congress on antiphospholipid antibodies task force reporton catastrophic antiphospholipid syndrome. Autoimmun. Rev. 2014; 13(7): 699-707.
8. Asherson R.A. The catastrophic antiphospholipid (Asherson’s) syndrome in 2004 – a review. Autoimmun. Rev. 2005; 4: 48-54.
9. Макацария А.Д., ред. Антифосфолипидный синдром – иммунная тромбофилия в акушерстве и гинекологии. 2-е изд. М.: Триада-Х, 2013. С. 234-6.
10. Go´mez-Puerta J.A., Espinosa G., Cervera R. Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy. Clin. Lab. Med 2013; 33(2): 391-400.
11. Stojanovich L., Marisavljevic D., Rovensky J., Djokovich A., Kozáková D., Milinic N. Clinical and laboratory features of the catastrophic antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 2009; 36(2-3): 74-9.
12. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T. et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum. 2002; 46(4): 1019-27.
13. Khamashta M., Taraborelli M., Sciascia S., Tincani A. Antiphospholipid syndrome. Best Pract. Res. Clin. Rheumatol. 2016; 30(1):133-48.
14. Насонов Е.Л. Антифосфолипидный синдром. М.: Литтерра, 2004. 440 .
15. Blank M., Cohen J., Toder V., Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc. Natl. Acad. Sci. USA. 1991; 88(8): 3069-73.
16. Bakimer R., Fishman P., Blank M., Sredni B., Djaldetti M., Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J. Clin. Invest. 1992;89(5): 1558-63.
17. Ornoy A., Yacobi S., Matalon S.T., Blank M., Blumenfeld Z., Miller R.K., Shoenfeld Y. The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus. 2003; 12(7): 573-8.
18. Carreras L.O., Defreyn G., Machin S.J., Vermylen J., Deman R., Spitz B., Van Assche A. Arterial thrombosis, intrauterine death and «lupus» antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet. 1981; 317(8214): 244-6.
19. Schorer A.E., Duane P.G., Woods V.L., Niewoehner D.E. Some antiphospholipid antibodies inhibit phospholipase A2 activity. J. Lab. Clin. Med. 1992; 120: 67-77.
20. Chamley L.W., McKay E.J., Pattison N.S. Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis. Thromb. Res. 1993; 71(2): 103-11.
21. Cariou R., Tobelem G., Soria C., Caen J. Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. N. Engl. J. Med. 1986; 314(18): 1193-4.
22. Rand J.H., Wu X.X., Guller S., Gil J., Guha A., Scher J., Lockwood C.J. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am. J. Obstet. Gynecol. 1994; 171(6): 1566-72.
23. Meroni P.L., di Simone N., Testoni C., D’Asta M., Acaia B., Caruso A. Antiphospholipid antibodies as cause of pregnancy loss. Lupus. 2004; 13(9): 649-52.
24. Vinatier D., Dufour P., Cosson M., Houpeau J.L. Antiphospholipid syndrome and recurrent miscarriages. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001; 96: 37-50.
25. Drakeley A.J., Quenby S., Farquharson R. Mid-trimester loss - appraisal of a screening protocol. Hum. Reprod. 1998; 13(7):1975-80.
26. Blank M., Krause I., Fridkin M., Keller N., Kopolovic J., Goldberg I. et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 2002; 109(6): 797-804.
27. Manco-Johnson M.J., Nuss R., Key N., Moertel C., Jacobson L., Meech S. et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J. Pediatr. 1996; 128(3):319-23.
28. Rodriguez-Pinto I., Espinosa G., Cervera R. Catastrophic APS in the context of other thrombotic microangiopathies. Curr. Rheumatol. Rep. 2015;17(1): 482.
29. Mar N., Kosowicz R., Hook K. Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss. J. Thromb. Thrombolysis. 2014; 38(2): 196-200.
30. Sibai B.M. Imitators of severe pre-eclampsia. Semin. Perinatol. 2009; 33(3): 196-205.
31. Bucciarelli S., Cervera R., Espinosa G., Gómez-Puerta J.A., Ramos-Casals M., Font J. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmun. Rev. 2006; 6(2): 72-5.
32. Go´mez-Puerta J.A., Sanin-Blair J., Galarza-Maldonado C. Pregnancy and catastrophic antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 2009; 36: 85-90.
33. Espinosa G., Berman H., Cervera R. Management of refractory cases of catastrophic antiphospholipid syndrome. Autoimmun. Rev. 2011; 10(11):664-8.
34. Lockshin M.D., Kim M., Laskin C.A., Guerra M., Branch D.W., Merrill J. et al. Lupus anticoagulant, but not anticardiolipin antibody, predicts adverse pregnancy outcome in patients with antiphospholipid antibodies. Arthritis Rheum. 2012; 64(7): 2311-8.
35. Hoayek J.G., Moussa H.N., Rehman H.A., Nasab S.H., Blackwell S.C., Sibai B.M. Catastrophic antiphospholipid syndrome in pregnancy, a diagnosisthat should not be missed. J. Matern. Fetal Neonatal Med. 2016; 29(24): 3950-5.
36. George J.N., Nester C.M., Mclntosh J.J. Syndromes of thrombotic microangiopathy associated with pregnancy. Hematology Am. Soc. Hematol. Educ. Program. 2015; 2015: 644-8.
37. Laszik Z.G., Kambham N., Silva F.G. Thrombotic microangiopathies. In: Jennett J.C., D’Agati V.D., Olson J.L., Silva F.G., eds. Heptinstall’s pathology of the kidney. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2014: 699-762.
38. Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2009; 361(17): 1676-87.
39. Haram K., Svendsen E., Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009; 9: 8.
40. Steegers E.A., von Dadelszen P., Duvekot J.J., Pijnenborg R. Pre-eclampsia. Lancet. 2010; 376(9741): 631-44.
41. Moake J.L., Rudy C.K., Troll J.H., Weinstein M.J., Colannino N.M., Azocar J. et al. Unusually large plasma factor VIII: vonWillebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N. Engl. J. Med. 1982; 307(23): 1432-5.
42. George J.N., Nester C.M. Syndromes of thrombotic microangiopathy. N. Engl. J. Med. 2014; 371(7): 654-66.
43. Raife T., Montgomery R. New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Rev. Clin. Exp. Hematol. 2001; 5(3): 236-61.
44. Moatti-Cohen M., Garrec C., Wolf M., Boisseau P., Galicier L., Azoulay E. et al. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-associated thrombotic thrombocytopenic purpura. Blood. 2012; 119(24):5888-97.
45. Scully M., Thomas M., Underwood M., Watson H., Langley K., Camilleri R.S. et al. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood. 2014; 124(2): 211-9.
46. Fuchs W.E., George J.N., Dotin L.N., Sears D.A. Thrombotic thrombocytopenic purpura. Occurrence two years apart during late pregnancy in two sisters. JAMA. 1976; 235(19): 2126-7.
47. Jiang Y., McIntosh J.J., Reese J.A., Deford C.C., Kremer Hovinga J.A., Lämmle B. et al. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014; 123(11): 1674-80.
48. Austin S.K., Starke R.D., Lawrie A.S., Cohen H., Machin S.J., Mackie I.J. The VWF/ADAMTS13 axis in antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction. Br. J. Haematol. 2008; 141(4):536-44.
49. Ardissino G., Wally Ossola M., Baffero G.M., Rigotti A., Cugno M. Eculizumab for atypical hemolytic uremic syndrome in pregnancy. Obstet. Gynecol. 2013; 122(2, Pt 2): 487-9.
50. Bruel A., Kavanagh D., Noris M., Delmas Y., Wong E.K.S., Bresin E. et al. Hemolytic uremic syndrome in pregnancy and post-partum. Clin. J. Am. Soc. Nephrol. 2017; 12(8): 1237-47.
51. Tsai H.M., Shulman K. Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura. Eur. J. Haematol. 2003; 70(3): 183-5.
52. George J.N. Thrombotic thrombocytopenic purpura: a syndrome that keeps evolving. J. Clin. Apher. 2004; 19(2): 63-5.
53. Lonze B.E., Singer A.L., Montgomery R.A. Eculizumab and renal transplantation in a patient with CAPS. N. Engl. J. Med. 2010; 362(18): 1744-5.

Поступила 10.06.2019

Принята в печать 21.06.2019